Securities & Exchange Commission of Pakistan

OncoSec Announces Pricing of $3.5 Million Public Offering

Retrieved on: 
Wednesday, November 30, 2022
SAN, Immune system, Madison Avenue, Telephone, Prospectus, Tumor microenvironment, Annual report, Security (finance), Sale, Electroporation, SEC filing, Risk, Research, Form, Securities & Exchange Commission of Pakistan

The closing of the offering is expected to occur on or about December 1, 2022, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about December 1, 2022, subject to the satisfaction of customary closing conditions.
  • A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.
  • The offering is being made only by means of a prospectus forming part of the effective registration statement.
  • OncoSec Medical Incorporated (the "Company," "OncoSec," "we" or "our") is a biotechnology company focused on developing intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.

IceCure's ProSense Featured in Poster Presentation at Radiological Society of North America's 2022 Annual Meeting

Retrieved on: 
Wednesday, November 30, 2022
CMS, Interventional radiology, Kidney, Food, Poster, RSNA, Centers for Medicare & Medicaid Services, Update, Patient, Regulation of tobacco by the U.S. Food and Drug Administration, Annual report, FDA, Radiological Society of North America, Annual general meeting, Classification, De novo, MD, Breast cancer, Interim, Neoplasm, Medicare, Diagnosis, CentraState Medical Center, Genta (company), LINK, Risk, TASE, ICE3, Securities & Exchange Commission of Pakistan, Clinical trial, CE marking, Breast, Freezing, Medical imaging

That Is The Question: Cryoablation For The Treatment Of Breast Cancer"

Key Points: 
  • That Is The Question: Cryoablation For The Treatment Of Breast Cancer"
    CAESAREA, Israel, Nov. 30, 2022 /PRNewswire/ -- IceCure Medical Ltd .
  • (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense System that destroys tumors by freezing, today announced that ProSense is featured in a poster presentation titled "To Freeze Or Not To Freeze?
  • That Is The Question: Cryoablation For The Treatment Of Breast Cancer" at RSNA 2022 , the Radiological Society of North America's ("RSNA") 108th Scientific Assembly and Annual Meeting which takes place from November 27th to December 1st, 2022 in Chicago.
  • RSNA is the largest radiology society in the world with over 48,000 members in the United States, representing 31 radiologic sub-specialties sharing state-of-the-art radiological innovations.

Altamira Therapeutics Announces Launch of Bentrio in Hong Kong by its Partner Nuance Pharma

Retrieved on: 
Wednesday, November 30, 2022
COVID-19, Marketing, Allergen, RNA, Cell, Nose, Risk, Tinnitus, Allergic rhinitis, Therapy, Exercise, Hearing loss, Securities & Exchange Commission of Pakistan, Vertigo, Sale, Virus, Nasal mucosa, Nasal spray, FDA, Form 6-K, Person, Pharmaceutical industry, Fine chemical, Nuance

Nuance Pharma to file for marketing approval in Macao, Mainland China and South Korea in 2023

Key Points: 
  • Nuance Pharma to file for marketing approval in Macao, Mainland China and South Korea in 2023
    Altamira Therapeutics Ltd. (NASDAQ: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announcedthat its licensee and distribution partner Nuance Pharma has launched its Bentrio nasal spray in Hong Kong.
  • Bentrio is being marketed in Hong Kong to help with protection against both airborne viruses as well as allergens.
  • We are very excited to see our partner Nuance Pharma take the first step in bringing Bentrio to the promising Chinese market, commented Thomas Meyer, Altamiras founder, Chairman and CEO.
  • We look forward to working together with Nuance Pharma in requesting marketing approval for Bentrio in Macao, Mainland China and South Korea in 2023.

Leju Reports First Half Year 2022 Results

Retrieved on: 
Wednesday, November 30, 2022
Marketing, COVID-19, Tencent, Nature, Generally Accepted Accounting Principles (United States), Table, Advertising, Partnership, App Store (iOS/iPadOS), Income tax, Securities & Exchange Commission of Pakistan, Government, Sina Corp, City, Annual report, NYSE, ADS, GAAP, SINA, Online shopping, Bank, Reinsurance, Cryptocurrency

BEIJING, Nov. 30, 2022 /PRNewswire/ -- Leju Holdings Limited ("Leju" or the "Company") (NYSE: LEJU), a leading online-to-offline ("O2O") real estate services provider in China, today announced its unaudited financial results for the six months ended June 30, 2022.

Key Points: 
  • BEIJING, Nov. 30, 2022 /PRNewswire/ -- Leju Holdings Limited ("Leju" or the "Company") (NYSE: LEJU), a leading online-to-offline ("O2O") real estate services provider in China, today announced its unaudited financial results for the six months ended June 30, 2022.
  • See "About Non-GAAP Financial Measures" and "Unaudited Reconciliation of GAAP and Non-GAAP Results" below for more information about the non-GAAP financial measures included in this press release.
  • Since January 1, 2022, Leju has not recognized the revenue from such customers until the actual receipt of the transaction consideration.
  • Leju Holdings Limited ("Leju") (NYSE: LEJU) is a leading e-commerce and online media platform for real estate and home furnishing industries in China, offering real estate e-commerce, online advertising and online listing services.

Just Energy Reports Fiscal Second Quarter 2023 Results

Retrieved on: 
Tuesday, November 29, 2022
Growth, Energy, Mass marketing fraud, Just Energy, NEX, Weather, Ontario Superior Court of Justice, Electricity, MD, Carbon, Sale, Transaction, Securities & Exchange Commission of Pakistan, GAAP, CCAA, Renewable energy, Security (finance), Video game

TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Just Energy Group Inc. (Just Energy or the Company) (NEX:JE.H; OTC:JENGQ), a retail energy provider specializing in electricity and natural gas commodities and bringing energy efficient solutions, carbon offsets and renewable energy options to customers, today announced its second quarter results for fiscal year 2023.

Key Points: 
  • TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Just Energy Group Inc. (Just Energy or the Company) (NEX:JE.H; OTC:JENGQ), a retail energy provider specializing in electricity and natural gas commodities and bringing energy efficient solutions, carbon offsets and renewable energy options to customers, today announced its second quarter results for fiscal year 2023.
  • The Companys second fiscal quarter 2023 results and prior comparable periods are expressed in US dollars.
  • Mass Markets RCE Net Adds for the quarter was a gain of 27,000 compared to a gain of 9,000 for the prior comparable quarter, driven by the increase in customer additions.
  • Fiscal Second Quarter Financial Highlights:

Securian Financial and Qualified Plan Advisors introduce highly personalized managed account solution for workplace retirement plans

Retrieved on: 
Tuesday, November 29, 2022
Other Professional Services, Insurance, Human Resources, Finance, Health, Consulting, Professional Services, Health Insurance, QPA, Risk, Insurance, Securian Financial Group, Retirement, Education, Generally Accepted Recordkeeping Principles, Securities & Exchange Commission of Pakistan, Health, Family, Finance, Financial adviser, Stadion

Securian Financial is expanding its retirement plan distribution relationship with Qualified Plan Advisors (QPA) with the introduction of the QPA Managed Account Servicean advisor managed account solution, built with Stadion Money Management, that maximizes personalization to manage risk and help employees of all ages reach retirement income goals.

Key Points: 
  • Securian Financial is expanding its retirement plan distribution relationship with Qualified Plan Advisors (QPA) with the introduction of the QPA Managed Account Servicean advisor managed account solution, built with Stadion Money Management, that maximizes personalization to manage risk and help employees of all ages reach retirement income goals.
  • We are excited about creating solutions that are the right fit for an organizations people via Securian Financial and Stadion.
  • We are delighted to work with an industry-leading firm like Qualified Plan Advisors, said Steve Chappell, Securian Financial vice president for retirement solutions distribution.
  • Securian Financials qualified retirement plan products are offered through a group variable annuity contract issued by Minnesota Life Insurance Company.

Eyenovia Announces $15 Million Credit Facility with Avenue Venture Debt Fund

Retrieved on: 
Tuesday, November 29, 2022
Marketing, COVID-19, Silicon Valley Bank, Silicon, Food, Presbyopia, Mydriasis, Avenue Capital Group, Securities & Exchange Commission of Pakistan, Myopia, Food and Drug Administration, Therapy, FDA, Pharmaceutical industry, Risk management, Bank, Avenue

Per the terms of the agreement, Eyenovia received $10 million of gross proceeds at closing (approximately $9.5 million net).

Key Points: 
  • Per the terms of the agreement, Eyenovia received $10 million of gross proceeds at closing (approximately $9.5 million net).
  • The Avenue facility replaces the companys Silicon Valley Bank facility, which was recently paid off.
  • The Avenue Venture Debt Fund seeks to provide creative financing solutions to high-growth, venture capital-backed technology and life science companies.
  • The Avenue Venture Debt fund is part of the larger group of funds of Avenue Capital Group.

Cognition Therapeutics Highlights Phase 2 SHIMMER Study of CT1812 in Dementia with Lewy Bodies in Presentation at CTAD

Retrieved on: 
Monday, November 28, 2022
Lewy, COVID-19, Pathology, National Institute on Aging, Patient, Dementia, Head, University, DLB, Synapse, Cognition, Therapy, Brain, Degenerative disease, Sleep, Retina, Protein, Anxiety, Central nervous system, SHIMMER, LBDA, Lewy body, Behavior, Hallucination, Intellectual property, Risk, Vance DeGeneres, NIA, Lewy Body Dementia Association, Delusion, Securities & Exchange Commission of Pakistan, MPH, Neuron, Safety, Pharmaceutical industry, MD

The Phase 2 SHIMMER (COG1201) study is intended to assess the safety, tolerability, and efficacy of CT1812 in individuals with dementia with Lewy bodies (DLB).

Key Points: 
  • The Phase 2 SHIMMER (COG1201) study is intended to assess the safety, tolerability, and efficacy of CT1812 in individuals with dementia with Lewy bodies (DLB).
  • The SHIMMER study is being conducted at over 30 sites in the United States, many of which are LBDA centers of excellence.
  • DLB is caused by a build-up of a protein, -synuclein, which forms deposits, called Lewy bodies, in the brain.
  • We are currently investigating our lead candidate CT1812 in clinical programs in Alzheimers disease, dementia with Lewy bodies (DLB) and dry age-related macular degeneration (dry AMD).

EnLink Midstream Announces Executive Leadership Changes

Retrieved on: 
Monday, November 28, 2022
Carbon, Permian, Growth, CFO, CCO, NGL, Operational excellence, Economics, University, Multimedia, Carbon Solutions Global, Chief commercial officer, Acquisition, Corporate development, The Advisory Board Company, Natural gas, Transport, Senior advisor, Securities & Exchange Commission of Pakistan, Report, Baylor University, Trans Global Projects Group, Augustus A. Bird, Security (finance), LyondellBasell, NYSE, National Institute of Technology, Tiruchirappalli, Business administration, Bachelor of Business Administration, Gulf Coast of the United States, Bachelor of Science in Information Technology, Master of Science in Global Finance, Safety, Management, Maintenance, Science, Engineering

DALLAS, Nov. 28, 2022 /PRNewswire/ -- EnLink Midstream, LLC (NYSE: ENLC) (EnLink) announced today that the EnLink Board of Directors (Board) have appointed Benjamin D. Lamb as Executive Vice President and Chief Financial Officer (CFO) and Walter Pinto as Executive Vice President and Chief Operating Officer (COO).

Key Points: 
  • DALLAS, Nov. 28, 2022 /PRNewswire/ -- EnLink Midstream, LLC (NYSE: ENLC) (EnLink) announced today that the EnLink Board of Directors (Board) have appointed Benjamin D. Lamb as Executive Vice President and Chief Financial Officer (CFO) and Walter Pinto as Executive Vice President and Chief Operating Officer (COO).
  • The CCO will join the EnLink Executive Leadership Team and will focus on strategically growing the company's strong gathering and processing segments alongside its new carbon capture transportation business.
  • EnLink Midstream reliably operates a differentiated midstream platform that is built for long-term, sustainable value creation.
  • Headquartered in Dallas, EnLink is publicly traded through EnLink Midstream, LLC (NYSE: ENLC).

Fanhua Announces Execution of a Term Sheet to Acquire Majority Interests in Zhongrong Smart Finance Information Technology Co., Ltd.

Retrieved on: 
Thursday, November 24, 2022
COVID-19, Term sheet, Insurance, Life, Policy, Securities & Exchange Commission of Pakistan, Travel, Annual report, Health, Acquisition, Security (finance), Health insurance, Risk management, Shanghai Shijie Fanhua Bao

GUANGZHOU, China, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Fanhua Inc. (Fanhua or the Company) (Nasdaq: FANH), a leading independent financial services provider in China, today announced that it has signed a term sheet (the Term Sheet) with the existing shareholders of Zhongrong Smart Finance Information Technology Co., Ltd. (Zhongrong) to acquire 57.73% equity interests of Zhongrong in an all-stock transaction.

Key Points: 
  • GUANGZHOU, China, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Fanhua Inc. (Fanhua or the Company) (Nasdaq: FANH), a leading independent financial services provider in China, today announced that it has signed a term sheet (the Term Sheet) with the existing shareholders of Zhongrong Smart Finance Information Technology Co., Ltd. (Zhongrong) to acquire 57.73% equity interests of Zhongrong in an all-stock transaction.
  • Zhongrong offers life insurance products through a network of nearly 300 non-affiliated regional insurance agencies.
  • In 2021, the gross written premiums of its life insurance business reached RMB1.4 billion, of which the first-year premiums were approximately RMB730 million.
  • As a leading managing general agency in China, Zhongrong has unique advantages in compliance and quality management.